title: The impact of vitamin C supplementation in pregnancy and in vitro upon fetal membrane strength and remodeling.
abstract: Generation of reactive oxygen species (ROS) has been suggested as a mechanism of fetal membrane (FM) weakening leading to rupture, particularly with preterm premature rupture of the fetal membranes (PROM). In vitro, FM incubation with tumor necrosis factor (TNF) mimics physiological FM weakening, concomitant with generation of ROS and collagen remodeling. Proinflammatory cytokines are also postulated to have a role in the development of the FM physiological weak zone where rupture normally initiates in-term gestations. We hypothesized that antioxidant treatment may block ROS development and resultant FM weakening. Two studies examining antioxidant effects upon FM strength were conducted, one in vivo and the other in vitro. Fetal membrane of patients enrolled in a multicenter placebo-controlled trial to determine the effect of vitamin C (1 g/day) and vitamin E (400 IU/day) upon complications of pre-eclampsia were examined for FM biomechanical properties and biochemical remodeling at birth. Separately, biomechanics and biochemical markers of remodeling were determined in FM fragments incubated with TNF with or without vitamin C preincubation. Supplemental dietary vitamin C in combination with vitamin E did not modify rupture strength, work to rupture, or matrix metalloproteinase-9 (MMP9; protein or activity) either within or outside the term FM physiological weak zone. In vitro, TNF decreased FM rupture strength by 50% while increasing MMP9 protein. Vitamin C did not inhibit these TNF-induced effects. Vitamin C alone had a weakening effect on FM in vitro. We speculate that vitamin C supplementation during pregnancy will not be useful in the prevention of preterm PROM.
authors.affiliation: From the Department of Reproductive Biology, Case Western Reserve University, Cleveland, OH 44109, USA. bmm12@case.edu
authors.forename: Brian M
authors.initials: BM
authors.lastname: Mercer
authors.forename: Adli
authors.initials: A
authors.lastname: Abdelrahim
authors.forename: Robert M
authors.initials: RM
authors.lastname: Moore
authors.forename: Jillian
authors.initials: J
authors.lastname: Novak
authors.forename: Deepak
authors.initials: D
authors.lastname: Kumar
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Mansour
authors.forename: Marina
authors.initials: M
authors.lastname: Perez-Fournier
authors.forename: Cynthia J
authors.initials: CJ
authors.lastname: Milluzzi
authors.forename: John J
authors.initials: JJ
authors.lastname: Moore
mesh_terms: D000328:Adult; D001205:Ascorbic Acid / Q000008:administration & dosage*; D019587:Dietary Supplements; D005321:Extraembryonic Membranes / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000201:enzymology / Q000517:prevention & control; D006801:Humans; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D009924:Organ Culture Techniques; D011247:Pregnancy; D055815:Young Adult
chemical_list: D020780:Matrix Metalloproteinase 9; D001205:Ascorbic Acid